Supernus Pharmaceuticals Inc (SUPN) stock news · rev $719.0M
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This SUPN news page leads with what Supernus Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for SUPN yet. We will not pad this page with generic market recap.
Latest reported SUPN revenue for 2025-12-31 was $719.0M. Net income was -$38.5M. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. SUPN currently screens at market cap $2.53B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SUPN stock page; for the tape open the quote page.
SUPN stock news FAQ
What are SUPN's latest revenue and net income?
Latest cached Supernus Pharmaceuticals Inc (SUPN) revenue for Dec 31, 2025 was $719.0M. Net income was -$38.5M. Statements: https://lician.com/financials/supn
How did SUPN revenue change from the prior cached period?
Cached Supernus Pharmaceuticals Inc (SUPN) revenue was up 8.6% from $661.8M (Dec 31, 2024) to $719.0M (Dec 31, 2025). Statements: https://lician.com/financials/supn
What is SUPN's market cap?
Supernus Pharmaceuticals Inc (SUPN) market cap is $2.53B on the latest cached fundamentals snapshot.
What kind of company is SUPN?
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is SUPN stock news listed?
Cached stock news for Supernus Pharmaceuticals Inc (SUPN) is listed at https://lician.com/news/supn. Filings: https://lician.com/sec/supn
Not investment advice.